Hydrapres (WAR:HPS) Other Stockholders Equity: zł1.51 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:HPS Hydrapres SA WAR:HPS
34 GF Score
Price zł0.44
GF Value zł0.29
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hydrapres Other Stockholders Equity?

Hydrapres WAR:HPS 34 Other Stockholders Equity is zł1.51 Mil as of Mar. 2026. GuruFocus rates WAR:HPS with a GF Score™ of 34/100 and a GF Value™ of zł0.29 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Hydrapres's Other Stockholders Equity for the quarter that ended in Mar. 2026 was zł1.51 Mil.

Hydrapres's quarterly Other Stockholders Equity declined from Sep. 2025 (zł1.70 Mil) to Dec. 2025 (zł0.00 Mil) but then increased from Dec. 2025 (zł0.00 Mil) to Mar. 2026 (zł1.51 Mil).

Hydrapres's annual Other Stockholders Equity increased from Dec. 2023 (zł-0.00 Mil) to Dec. 2024 (zł0.00 Mil) and increased from Dec. 2024 (zł0.00 Mil) to Dec. 2025 (zł0.00 Mil).

Hydrapres Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Hydrapres's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hydrapres Other Stockholders Equity Chart

Hydrapres Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 -0.00 0.00 0.00

Hydrapres Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.00 1.70 0.00 1.51
WAR:HPS
34GF Score
Hydrapres SA WAR:HPS
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hydrapres Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of zł1.51 Mil mean?
Hydrapres (WAR:HPS) has a Other Stockholders Equity of zł1.51 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Hydrapres and its competitors.
Is Hydrapres' Other Stockholders Equity too high?
Hydrapres' current Other Stockholders Equity is zł1.51 Mil. Overall, Hydrapres has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hydrapres' Other Stockholders Equity compare to GEV and ETN?
Hydrapres' Other Stockholders Equity of zł1.51 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for an Industrial Products company?
A good Other Stockholders Equity depends on the Industrial Products industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Hydrapres and its competitors. Hydrapres's current Other Stockholders Equity is zł1.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hydrapres stock overvalued right now?
Based on GuruFocus' analysis, Hydrapres (WAR:HPS) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.29, compared to a current price of zł0.44 — trading 51% above its estimated fair value. The current Other Stockholders Equity is zł1.51 Mil. Hydrapres' overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Hydrapres (WAR:HPS), the current Other Stockholders Equity is zł1.51 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hydrapres (WAR:HPS) Overvalued in 2026?

Based on GuruFocus' analysis, Hydrapres stock appears to be overvalued. The current stock price of zł0.44 is trading 51% above its estimated GF Value™ of zł0.29. GuruFocus considers Hydrapres to be Significantly Overvalued.

Key valuation signals for WAR:HPS:

  • Other Stockholders Equity: zł1.51 Mil
  • GF Value™: zł0.29 vs. price of zł0.44 (51% above fair value)
  • GF Score™: 34/100 with 6 warning signs

No single metric tells the full story. See the WAR:HPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hydrapres Business Description

Address Ulica Haska 7, Solec Kujawski, POL, 86-050
Hydrapres SA is engaged in the construction of complex progressive dies with a length of up to 3200mm. It designs and produces machines and industry appliances. Its business activities include assembly of assemblies consisting of stamped elements and normal, designing of developed dies & welding tools and construction of progressive dies in own tool shop, production of multi-gear dies and construction of one-way dies.
34GF Score

Get the complete analysis for WAR:HPS

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.44
Price
zł0.29
GF Value